The first ingestible capsule for eradicating Helicobacter pylori infection through photodynamic therapy

Project description

Stomach cancer meets its match in a photoactivated oral capsule

Fields of science

• natural sciences › biological sciences › microbiology › bacteriology
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › antibiotics
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance › antibiotic resistance
• medical and health sciences › basic medicine › physiology › homeostasis
• medical and health sciences › clinical medicine › gastroenterology

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

PROBIOMEDICA SRL

Net EU contribution

€ 50 000,00

Address

Via Di Bellosguardo 2 Rosso
50124 Firenze
Italy

Region

Centro (IT) › Toscana › Firenze

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 50 000,00